0001209191-23-026744.txt : 20230502
0001209191-23-026744.hdr.sgml : 20230502
20230502190458
ACCESSION NUMBER: 0001209191-23-026744
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230429
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Teehan Brendan
CENTRAL INDEX KEY: 0001891900
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 23881109
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 12830 EL CAMINO REAL, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-29
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001891900
Teehan Brendan
C/O ACADIA PHARMACEUTICALS INC.
12830 EL CAMINO REAL, SUITE 400
SAN DIEGO
CA
92130
0
1
0
0
EVP, COO, Head of Commercial
0
Common Stock
2023-04-29
4
M
0
1567
0.00
A
10035
D
Common Stock
2023-05-01
4
S
0
548
21.18
D
9487
D
Restricted Stock Units
2023-04-29
4
M
0
1567
0.00
D
Common Stock
1567
0
D
The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
50% of the shares subject to the restricted stock units vest on each of April 29, 2022 and April 29, 2023.
/s/ Austin D. Kim, Attorney-in-Fact
2023-05-02